Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NICE changes rules for end-of-life treatments

This article was originally published in Scrip

Executive Summary

Patients in England and Wales who are expected to die within two years may be considered for more expensive life-extending treatments in the national health service than has been the case until now. The National Institute for health and Clinical Excellence(NICE) has published new guidance on the circumstances in which its cost-effectiveness rules can be set aside for end-of-life patients.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC007717

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel